RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma

International Journal of Cancer

Volumn 109, Issue 6, 2004, Pages 839-847

  Chow, Lillian Shuk Nga ^a   Lo, Kwok Wai ^a   Kwong, Joseph ^a   To, Ka Fai ^a   Tsang, Kam Sze ^a   Lam, Ching Wan ^a   Dammann, Reinhard ^b   Huang, Dolly P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Chromosome 3p21.3; Nasopharyngeal carcinoma; RASSF1A; Tumor suppressor

Indexed keywords

101F6 GENE; ARTICLE; BLU GENE; CACNA2D2 GENE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 3P; CHROMOSOME DELETION; DNA METHYLATION; FUS1 GENE; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; HUMAN; HUMAN CELL; HYAL2 GENE; MOLECULAR CLONING; NASOPHARYNX CARCINOMA; NPRL2 GENE; NUCLEOTIDE SEQUENCE; PL6 GENE; PRIORITY JOURNAL; PROMOTER REGION; RASSF1A GENE; RASSF1C GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; AZACITIDINE; CELL CYCLE; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 3; COLONY-FORMING UNITS ASSAY; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 2442482316     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20079     Document Type: Article

References (33)

1. Hui ABY, Lo KW, Leung SF, Teo PM, Mak KF, To KF, Wong N, Choi PHK, Lee JCK, Huang DP. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 1999;82:498-503.
2. Lo KW, Teo PM, Hui ABY, To KF, Tsang YS, Chan SYY, Mak KF, Lee JC, Huang DP. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000;60:3348-53.
3. Chan ASC, To KF, Lo KW, Mak KF, Pak W, Chiu B, Tse GMK, Ding M, Li X, Lee JCK, Huang DP. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 2000;60:5365-70.
4. Lo KW, Tsao SW, Leung SF, Choi PHK, Lee JCK, Huang DP. Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinoma. Int J Oncol 1994;43:936-9.
5. Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 1998;95:3042-7.
6. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997;71:27-92.
7. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000;60:6116-33.
8. Sekido Y, Ahmadian M, Wistuba II, Latif F, Bader S, Wei MH, Duh FM, Gazdar AF, Lerman MI, Minna JD. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene 1998;16:3151-7.
9. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002;62:2715-20.
10. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
11. Dammann R, Yang G, Pfeifer GP. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001;61:3105-9.
12. Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res 2001;61:6688-92.
13. Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001;93:691-9.
14. Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res 2002;62:3698-701.
15. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res 2003;9:1441-5.
16. Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 2003;22:1866-71.
17. Lo KW, Kwong J, Hui ABY, Chan SYY, To KF, Chan ASC, Chow LSN, Teo PML, Johnson PJ, Huang DP. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001,61:3877-81.
18. Kwong J, Lo KW, To KF, Teo PML, Johnson PJ, Huang DP. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 2002;8:31-7.
19. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP, Avruch J. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncogene 2002;21:1381-90.
20. Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF, Seed B, Avruch J. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 2002,12:253-65.
21. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell-cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002;22:4309-18.
22. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, Wong N, Yuen PW, Lo AKF, Wong YC, Huang DP. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 2002;1590:150-8.
23. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. Nasopharyngeal carcinoma cell line (C666-1) consistently harboring Epstein-Barr virus. Int J Cancer 1999;83:121-6.
24. Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 2003;106:60-5.
25. Lo KW, Cheung ST, Leung SF, van Hasselt A, Tsang YS, Mak KF, Chung YF, Woo JKS, Lee JCK, Huang DP. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 1996,56:2721-5.
26. Carboni GL, Gao B, Nishizaki M, Xu K, Minna JD, Roth JA, Ji L. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene 2003;22:615-26.
27. Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, et al. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 2003;22:1580-8.
28. Liu XQ, Pan ZG, Li MZ, Jiang JH, Fu J, Long QX, Wang XZ, Zeng YX. Analysis of suppressive roles of BLU gene at 3p21.3 in nasopharyngeal carcinoma. Ai Zheng 2003;22:128-35.
29. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 2001;98:7504-9.
30. Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 1999;274:37538-43.
31. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF. Quantitative Epstein-barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 2002;8:2612-9.
32. Li JH, Huang D, Sun BF, Zhang X, Middledorp J, Klamut H, Liu FF. Efficacy of ionizing radiation combined with adenoviral p53 therapy in EBV-positive nasopharyngeal carcinoma. Int J Cancer 2000;87:606-10.
33. Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H, Liuu FF. Tumor-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res 2002;62:171-8.